Introduction to AMLOFAB-AT
AMLOFAB-AT is a carefully formulated combination tablet designed for effective management of hypertension. High blood pressure is a common cardiovascular condition that requires precise treatment to prevent complications such as stroke, heart attack, and kidney damage. AMLOFAB-AT combines two proven anti-hypertensive agents, Amlodipine Besylate 5 mg and Atenolol 50 mg, in a single tablet to provide comprehensive blood pressure control. Manufactured under WHO-GMP standards, this medicine ensures safety, efficacy, and consistency, making it a reliable choice for healthcare providers and patients seeking optimal hypertension management.
AMLOFAB-AT as a Combination Tablet
AMLOFAB-AT works as a dual-action anti-hypertensive medication that targets both vascular resistance and cardiac workload. Its combination of Amlodipine Besylate, a calcium channel blocker, and Atenolol, a beta-blocker, provides balanced management of elevated blood pressure. By addressing multiple mechanisms involved in hypertension, AMLOFAB-AT helps maintain stable blood pressure levels throughout the day, reduces cardiovascular strain, and minimizes the risk of long-term complications. Its convenient single-tablet formulation also improves patient compliance, which is critical for chronic hypertension management.
Composition & Strength
Each AMLOFAB-AT tablet contains:
- Amlodipine Besylate 5 mg
- Atenolol 50 mg
This combination ensures a synergistic effect for optimal blood pressure control. Amlodipine Besylate works on the blood vessels to relax and widen them, while Atenolol targets the heart by reducing heart rate and cardiac workload. The dual formulation provides effective hypertension management in a convenient once-daily dose, enhancing adherence to treatment.
Mechanism of Action
Amlodipine Besylate – Calcium Channel Blocker
Amlodipine Besylate relaxes and dilates blood vessels by blocking calcium entry into the vascular smooth muscles. This leads to reduced vascular resistance and improved blood flow, helping lower both systolic and diastolic blood pressure. Its long-acting effect ensures sustained blood pressure control throughout the day, reducing the risk of hypertension-related complications.
Atenolol – Beta-Blocker
Atenolol works by selectively blocking beta-1 receptors in the heart, leading to slower heart rate and reduced cardiac workload. By decreasing the force and frequency of heart contractions, Atenolol reduces oxygen demand and strain on the cardiovascular system. Combined with Amlodipine, it provides comprehensive blood pressure management by targeting both the heart and blood vessels.
Dual Mechanism for Effective Blood Pressure Control
AMLOFAB-AT’s combination therapy offers multiple advantages for patients with hypertension:
- Targets both vascular resistance and cardiac workload
- Reduces the risk of stroke, heart attack, and other complications
- Supports stable blood pressure throughout the day
- Convenient once-daily dosing improves patient compliance
- Suitable for a wide range of hypertensive patients
This dual mechanism ensures more effective and reliable control of elevated blood pressure compared to monotherapy, making AMLOFAB-AT a preferred choice for healthcare providers.
Conclusion
AMLOFAB-AT Tablets (Besylate 5 mg + Atenolol 50 mg) are a trusted and effective solution for managing hypertension. By combining a calcium channel blocker and a beta-blocker in a single tablet, it provides dual-action blood pressure control, reduces cardiac workload, and minimizes vascular resistance. Its sustained effectiveness, safety, and WHO-GMP quality standards make it suitable for long-term therapy. For patients and healthcare professionals seeking reliable hypertension management, AMLOFAB-AT offers convenience, efficacy, and comprehensive cardiovascular protection.